PNNL and Argonne researchers developed and tested a chemical process that successfully captures radioactive byproducts from used nuclear fuel so they could be sent to advanced reactors for destruction while also producing electrical power.
In the third year of the DISCOVR Consortium project, the consortium team has identified an algal strain that progressed successfully through multiple evaluation phases.
A new Co-Optima report describes an assessment of 400 biofuel-derived samples and identifies the top ten candidates for blending with petroleum fuel to improve boosted spark ignition engine efficiency.
Nitrogen oxides, also known as NOx, form when fossil fuels burn at high temperatures. When emitted from industrial sources such as coal power plants, these pollutants react with other compounds to produce harmful smog.
Eric Hoppe, senior scientist, was selected a 2019 American Chemical Society (ACS) fellow. Eric is being recognized for his contributions to analytical chemistry measurements and three decades of volunteer service to the ACS community.
Researchers at PNNL have developed a model that predicts outcomes from the algae hydrothermal liquefaction process in a way that mirrors commercial reality much more closely than previous analyses.
Researchers at PNNL have introduced an alternative method using a molecular-based pump that could potentially use a quarter less energy than the age-old mechanical pump.
Researchers at PNNL and their collaborators have made a significant improvement to a catalyst that is more rugged and can reduce tailpipe pollution at lower temperatures than existing methods.
Several years ago, a relatively new catalyst for vehicle emission control began showing failure. A team at PNNL found that this seemingly suicidal catalyst wasn’t actually self-destructing but was the victim of an external assailant.
Scientists created a fast-track tutorial that equips a neural network to tackle drug discovery and other applications where there's a shortage of precisely labeled chemical data.
A detailed analysis of blood samples from Ebola patients in Sierra Leone is providing clues about the progression of the effects of the virus and potential treatment pathways. The findings point to a critical role for a molecular pathway.